Onnit Krill Oil 1000 mg Review

Modestly real but overstated in marketing. Multiple comparative bioavailability studies (Ulven 2011, Maki 2009) found phospholipid-bound krill omega-3 produces roughly equivalent or slightly higher Omega-3 Index increase per gram of EPA+DHA delivered vs fish oil at the same dose. The 'per-mg absorption advantage' is real but small — typically 10-20%, not the 'dramatically superior' framing krill marketing implies. The mechanistic story (phospholipids integrate directly into cell membranes vs triglycerides requiring lipase hydrolysis) is mechanistically grounded but the practical bioavailability gap is modest.

Three reasons. First, krill harvesting is operationally harder than fish — it's done in Antarctic waters at depth using specialised vessels and managed under CCAMLR (Convention for the Conservation of Antarctic Marine Living Resources) quotas. Second, EPA+DHA concentration in krill is naturally lower than in fatty fish oil — ~25% of total lipid vs 30-50% for concentrated fish oil. Third, the phospholipid-extraction process is more complex than simple oil pressing. Combined, you're paying $5.25/g of EPA+DHA for Onnit Krill (Amazon, October 18, 2026) vs $0.40-1.00/g from fish — a premium of 5× or more that's partly cost-driven, not pure marketing markup.

Modestly. Onnit's panel lists 200 mcg astaxanthin per 2-softgel serving. Astaxanthin is a genuine antioxidant with documented effects on lipid stability (it's why krill oil oxidises slower than fish oil) and limited human data on cardiovascular and skin endpoints. Whether that amount is enough to drive clinical effects independent of the omega-3 is unclear — most astaxanthin clinical trials use dedicated 4-12 mg supplements, not the trace amounts in krill. Functionally: astaxanthin is a real value-add for oil stability, a small functional bonus for the user.

Currently yes, with caveats. The Antarctic krill fishery is managed under CCAMLR with conservative harvest quotas (~1% of estimated biomass annually) and most major krill oil brands hold MSC certification for the Antarctic fishery. The ecosystem concern is more long-term: krill are the foundational food source for whales, penguins, seals, and seabirds, and any future expansion of harvest quotas could have cascading effects. For now, Antarctic krill is one of the better-managed marine fisheries — but it's a tighter sustainability picture than wild Alaskan or anchovy/sardine sources.

Almost always Nordic Naturals on $/g math — $0.99/g of EPA+DHA vs Onnit Krill at $5.25/g, with the phospholipid-bound bioavailability advantage too small to compensate. Where Onnit Krill wins specifically: buyers who've tried fish oil (even premium TG-form) and still get aggressive fishy burps. Krill oil produces dramatically less repeat than even the best fish oil, plus the smaller softgel size helps. For fish-burp-intolerant buyers, krill is genuinely the right answer despite the premium. For everyone else, the math favours fish oil at lower $/g.

Yes, if you have a documented shellfish allergy. Krill are crustaceans (tiny shrimp-like animals) and contain proteins that can trigger reactions in shellfish-allergic users. Most krill oil is processed to minimise allergenic protein content, but residual exposure is possible and there are documented allergic reactions in the literature. If you have any shellfish allergy, default to algae-source omega-3 (Ovega-3) — same actives, zero crustacean exposure.

1. [1] Mozaffarian 2011 PMID 22051327 — Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. Comprehensive omega-3 cardiovascular review — establishes 10-33% triglyceride reduction at 2-4 g/day combined EPA+DHA. Krill oil at 4-8 caps/day reaches this protocol window but at significantly higher cost than fish-oil equivalents.
2. [2] Dyerberg 2010 (TG vs EE bioavailability) PMID 20638827 — Bioavailability of marine n-3 fatty acid formulations. Head-to-head bioavailability of TG, rTG, and EE forms — establishes the 30-50% absorption advantage of TG/rTG over EE in fish oil. Phospholipid-bound krill omega-3 sits closer to the TG/rTG absorption tier than to EE.
3. [3] Harris 2008 (Omega-3 Index) PMID 15208005 — The omega-3 index: a new risk factor for death from coronary heart disease?. Defined the Omega-3 Index as a CV risk biomarker. Index of 8%+ associated with lowest CHD mortality. Krill oil at 4 caps/day for 12 weeks moves the index toward target — same endpoint as fish oil, more expensive route.
4. [4] Serhan 2014 (resolvins) PMID 24899309 — Pro-resolving lipid mediators are leads for resolution physiology. Mapped the resolvin and protectin biosynthesis pathway from EPA + DHA — the molecular mechanism behind omega-3's anti-inflammatory effect. The pathway runs identically regardless of whether EPA+DHA arrives via triglyceride or phospholipid carrier.
5. [5] Sublette 2011 (depression meta) PMID 21939614 — Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression. EPA-dominant formulations (EPA:DHA ≥60%) significantly improved depression scores; DHA-dominant did not. Krill oil's EPA:DHA ratio varies by source but typically sits ~1.5-2:1 — borderline for the Sublette threshold and not the optimal formulation for mood-protocol use.